Muscle growth
Muscle & Strength: GH Secretagogues and Training Data
Hypertrophy and strength: where the evidence holds and where it is anecdote.
15 matching articles
Compound
5 September 2026 · 12 min read
Growth Hormone Secretagogues: One Approved Drug, Several Research Compounds, and the Difference
Tesamorelin is an FDA-approved medicine with phase 3 trial data. Ipamorelin and sermorelin are not approved for general use and rest on far thinner evidence. What separates a licensed GHRH analogue from an online 'GH peptide'.
Ipamorelin · Tesamorelin · Sermorelin · Growth hormone
31 August 2026 · 5 min read
Systematic Post-Exercise Recovery: A Methodological Review of 24-Hour Kinetics
An analytical evaluation of post-training recovery frameworks, examining physiological substrate restoration, parasympathetic tone re-establishment, and cellular repair timelines over a 24-hour cycle.
Growth hormone
31 August 2026 · 5 min read
Evaluating Mod GRF 1-29 (CJC-1295 Without DAC): Secretagogue Kinetics, Receptor Dynamics, and Experimental Limitations
An editorial review examining the short-acting GHRH analog Mod GRF 1-29 (CJC-1295 no DAC), its physiological mechanism, pulsatile release profiles, and comparative distinction from long-acting formulations.
Ipamorelin · CJC-1295 · Sermorelin · Growth hormone
31 August 2026 · 5 min read
Analyzing High-Profile Polytrauma Recovery: Peptides, Physiology, and the Evidence Gap
An editorial analysis of high-profile orthopedic recovery narratives, examining the biological mechanisms of polytrauma repair, preclinical peptide signaling, and the methodological challenges of multi-modal rehabilitation.
BPC-157 · TB-500 · Ipamorelin · CJC-1295
31 August 2026 · 4 min read
Sleep Architecture as a Metabolic and Immunological Regulator: An Analytical Review
A critical analysis of how nocturnal sleep stages orchestrate systemic metabolic homeostasis, neuro-glymphatic clearance, and cell-mediated immune dynamics.
Growth hormone
31 August 2026 · 5 min read
Sleep Architecture and Systemic Longevity: Mechanisms of Glymphatic Clearance and Endocrine Regulation
An editorial examination of sleep as an active bioregulatory process, detailing its impact on glymphatic waste clearance, somatotropic hormone secretion, metabolic control, and cellular repair.
Growth hormone
31 August 2026 · 6 min read
Preserving Lean Mass During GLP-1 Receptor Agonist Protocols: Physiology and Nutritional Countermeasures
Rapid body weight reduction induced by GLP-1 receptor agonists presents a major clinical challenge: preventing disproportionate lean mass loss. We review the physiological mechanisms and dietary strategies required to preserve skeletal muscle integrity.
Semaglutide · Tirzepatide
31 August 2026 · 6 min read
Dissecting Consumer Biometric Telemetry: Signal, Noise, and Protocol Context
A critical examination of wearable sensor metrics, evaluating the fidelity of heart rate variability, skin temperature, and sleep staging against clinical standards in performance monitoring.
Creatine
31 August 2026 · 6 min read
Beyond the Celebrity Spotlight: A Scientific Evaluation of Peptide Signaling and Dermal Remodeling
A critical, evidence-first assessment of injectable, topical, and oral peptide modalities popularized in mainstream anti-aging discussions, evaluating their pharmacokinetic realities and cellular mechanisms.
GHK-Cu · Ipamorelin · CJC-1295 · Sermorelin
31 August 2026 · 6 min read
Managing GLP-1 Discontinuation: Physiological Mechanisms and Post-Cessation Weight Rebound
An objective examination of neuroendocrine adaptations, resting metabolic rate alterations, lean mass retention, and strategy frameworks following GLP-1 receptor agonist cessation.
31 August 2026 · 6 min read
Thermal Stress Protocols and Cardiovascular Homeostasis: A Desk Review of Whole-Body Hyperthermia Literature
An evaluation of systemic hyperthermic exposure, analyzing physiological mechanisms, vascular hemodynamics, cellular stress responses, and methodological limitations in current clinical literature.
Growth hormone
31 August 2026 · 6 min read
Selectivity in Growth Hormone Secretagogues: A Desk Review of Ipamorelin
An editorial examination of ipamorelin’s receptor selectivity, its historical development, and the current state of preclinical research regarding growth hormone axis modulation.
Ipamorelin · Hexarelin · Growth hormone
31 August 2026 · 4 min read
Evaluating Ipamorelin: Selectivity, Endocrine Dynamics, and Preclinical Evidence
An editorial analysis of ipamorelin, examining its ghrelin-receptor selectivity, pulsatile growth hormone secretagogue profile, preclinical data on bone and gut motility, and key analytical considerations for research environments.
Ipamorelin · Growth hormone
31 August 2026 · 5 min read
Mechanistic Precision and Metabolic Trade-Offs: A Desk Review of Tesamorelin
An analytical evaluation of Tesamorelin, examining its structural stability as a GHRH analogue, visceral adiposity trial data, glycemic impact, and neurodegenerative research frontiers.
Ipamorelin · Tesamorelin · Growth hormone
31 August 2026 · 5 min read
Evaluating Sermorelin: Mechanistic Insights and Evidence in Somatotropic Axis Modulation
An editorial examination of Sermorelin acetate, analyzing its mechanism of action, pituitary feedback dynamics, and clinical evidence comparing GHRH secretagogues to direct growth hormone replacement.
Sermorelin · Growth hormone